Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,605,960
  • Shares Outstanding, K 227,649
  • Annual Sales, $ 1,477 M
  • Annual Income, $ 126,040 K
  • EBIT $ 115 M
  • EBITDA $ 128 M
  • 60-Month Beta 2.43
  • Price/Sales 1.82
  • Price/Cash Flow 46.20
  • Price/Book 6.37

Options Overview Details

View History
  • Implied Volatility 110.61% (+0.43%)
  • Historical Volatility 71.32%
  • IV Percentile 85%
  • IV Rank 59.86%
  • IV High 144.96% on 02/21/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 8) 2.24 (14.13%)
  • Put/Call Vol Ratio 0.48
  • Today's Volume 153,468
  • Volume Avg (30-Day) 145,981
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 1,027,713
  • Open Int (30-Day) 898,672
  • Expected Range 13.58 to 18.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.02
  • Number of Estimates 6
  • High Estimate 0.09
  • Low Estimate -0.04
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -81.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.46 +2.33%
on 02/19/26
31.30 -49.46%
on 01/20/26
-15.56 (-49.59%)
since 01/16/26
3-Month
15.46 +2.33%
on 02/19/26
40.99 -61.41%
on 12/05/25
-20.01 (-55.85%)
since 11/19/25
52-Week
15.46 +2.33%
on 02/19/26
70.43 -77.54%
on 07/31/25
-52.92 (-76.99%)
since 02/19/25

Most Recent Stories

More News
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada.

HIMS : 15.82 (-0.13%)
2 Profitable Stocks on Our Watchlist and 1 We Ignore

2 Profitable Stocks on Our Watchlist and 1 We Ignore

HIMS : 15.82 (-0.13%)
NOW : 107.37 (-0.41%)
MOG.A : 338.79 (+3.60%)
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

ACHC : 16.86 (-0.41%)
HIMS : 15.82 (-0.13%)
PRVA : 21.83 (+0.23%)
HALO : 72.04 (-1.63%)
RDNT : 70.50 (-1.58%)
As Hims & Hers Gets Hit With Major Wegovy Loss, Should You Buy the Dip in Deeply Oversold HIMS Stock?

Hims & Hers shares crater as Novo Nordisk files a lawsuit against the telehealth firm. BofA analysts see significant further downside in HIMS stock.

HIMS : 15.82 (-0.13%)
NVO : 48.45 (-1.58%)
Stocks making big moves yesterday: Shopify, Snowflake, Ryan Specialty, Merchants Bancorp, and Hims & Hers Health

Stocks making big moves yesterday: Shopify, Snowflake, Ryan Specialty, Merchants Bancorp, and Hims & Hers Health

SHOP : 123.80 (+1.78%)
RYAN : 41.33 (+2.43%)
SNOW : 179.20 (+1.77%)
HIMS : 15.82 (-0.13%)
MBIN : 45.05 (-3.01%)
Stocks Settle Higher on Strength in Tech

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.77%. March E-mini S&P...

AMAT : 369.83 (+0.14%)
APP : 412.00 (+1.88%)
TGNA : 20.87 (-0.38%)
B : 48.55 (+0.68%)
AVGO : 333.99 (+0.14%)
HL : 22.79 (+3.50%)
CDE : 24.06 (+6.51%)
HIMS : 15.82 (-0.13%)
WAT : 328.66 (+0.35%)
$IUXX : 24,797.34 (-0.41%)
ASML : 1,458.93 (-0.67%)
ZNH26 : 113-010 (+0.06%)
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”)...

HIMS : 15.82 (-0.13%)
Why Hims & Hers Health (HIMS) Stock Is Nosediving

Why Hims & Hers Health (HIMS) Stock Is Nosediving

HIMS : 15.82 (-0.13%)
Stocks Recover Early Losses as Tech Stocks Rebound

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.61%. March E-mini S&P futures (ESH26...

APO : 118.34 (-5.21%)
APP : 412.00 (+1.88%)
TGNA : 20.87 (-0.38%)
B : 48.55 (+0.68%)
AVGO : 333.99 (+0.14%)
HL : 22.79 (+3.50%)
CDE : 24.06 (+6.51%)
HIMS : 15.82 (-0.13%)
WAT : 328.66 (+0.35%)
$IUXX : 24,797.34 (-0.41%)
ASML : 1,458.93 (-0.67%)
ZNH26 : 113-010 (+0.06%)
Stocks Slip Ahead of this Week's US News on Jobs and Inflation

The S&P 500 Index ($SPX ) (SPY ) today is down -0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.17%. March E-mini S&P futures...

APO : 118.34 (-5.21%)
TGNA : 20.87 (-0.38%)
HIMS : 15.82 (-0.13%)
TXN : 218.05 (-2.36%)
WAT : 328.66 (+0.35%)
$IUXX : 24,797.34 (-0.41%)
ZNH26 : 113-010 (+0.06%)
DT : 36.28 (-0.38%)
MNDY : 76.00 (-1.30%)
ESH26 : 6,889.00 (+0.17%)
STX : 408.97 (-3.58%)
BDX : 182.47 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 20%. The market is in extreme oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 17.52
2nd Resistance Point 17.03
1st Resistance Point 16.43
Last Price 15.82
1st Support Level 15.34
2nd Support Level 14.85
3rd Support Level 14.25

See More

52-Week High 70.43
Fibonacci 61.8% 49.43
Fibonacci 50% 42.94
Fibonacci 38.2% 36.46
Last Price 15.82
52-Week Low 15.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar